NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding NexImmune, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 52 | 2 | 46 | −4 |
| Shares | 9.55M | 21.9K | 8.30M | −1.23M (−12.9%) |
| Value | $40.1M | $93.0K | $13.4M | −$26.7M (−66.6%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held NexImmune, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kettle Hill Capital Management, LLC | 272,447 | $439.0K | 0.11% |
| Millennium Management LLC | 181,308 | $292.0K | 0.00% |
| Ergoteles LLC | 86,200 | $139.0K | 0.00% |
| Citadel Advisors LLC | 42,321 | $68.0K | 0.00% |
| Goldman Sachs Group Inc | 29,084 | $47.0K | 0.00% |
| SEI Investments Co | 26,621 | $43.0K | 0.00% |
| Susquehanna International Group, LLP | 26,629 | $43.0K | 0.00% |
| Bailard, Inc. | 20,285 | $33.0K | 0.00% |
| Qube Research & Technologies Ltd | 15,846 | $26.0K | 0.00% |
| Truist Financial Corp | 10,000 | $18.0K | 0.00% |
| CIBC Private Wealth Group, LLC | 10,253 | $17.0K | 0.00% |
| Credit Suisse AG | 9 | $0 | 0.00% |
| Ellevest, Inc. | 5 | $0 | 0.00% |
Sold out (17)
Institutions that held NexImmune, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| JPMorgan Chase & Co | 255,329 | $1.07M |
| Kingdon Capital Management, L.L.C. | 117,962 | $497.0K |
| Renaissance Technologies LLC | 73,661 | $310.0K |
| Edgewood Management LLC | 56,015 | $236.0K |
| Bank of New York Mellon Corp | 40,700 | $171.0K |
| Charles Schwab Investment Management Inc | 37,133 | $157.0K |
| Nuveen Asset Management, LLC | 36,709 | $76.0K |
| Corient Capital Partners, LLC | 16,882 | $71.0K |
| Rhumbline Advisers | 14,001 | $59.0K |
| Deutsche Bank AG | 9,579 | $40.0K |
| American International Group, Inc. | 8,765 | $37.0K |
| California State Teachers Retirement System | 7,565 | $32.0K |
| Allspring Global Investments Holdings, LLC | 3,817 | $16.0K |
| Amalgamated Bank | 2,752 | $12.0K |
| STRS Ohio | 1,500 | $6.00K |
| Royal Bank of Canada | 1,300 | $6.00K |
| Ameritas Investment Partners, Inc. | 1,353 | $6.00K |
Not filed for Q2 2022 yet (2)
Institutions that held NexImmune, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 19,190 | $81.0K |
| Amalgamated Financial Corp. | 2,752 | $12.0K |